Provided by Tiger Trade Technology Pte. Ltd.

WisdomTree BioRevolution Fund

23.24
-0.4287-1.81%
Post-market: 23.16-0.0763-0.33%16:10 EDT
Volume:3K
Turnover:60.42K
Market Cap:3.02M
PE:- -
High:23.66
Open:23.66
Low:23.01
Close:23.67
52wk High:24.09
52wk Low:14.14
Shares:130.00K
Float Shares:130.00K
Volume Ratio:0.48
T/O Rate:2.01%
Dividend:0.77
Dividend Rate:3.32%
ROE:--
ROA:--
PB:--
PE(LYR):- -

Loading ...

Top Midday Gainers

MT Newswires Live
·
Aug 20

U.S. Stocks on the MOVE-ServiceNow, Zoom, US Homebuilders

Reuters
·
Aug 20

Moderna upgraded to Neutral from Underperform at BofA

TIPRANKS
·
Aug 20

Short Sellers Lose $4.8 Billion as Moderna Stock (MRNA) Soars 150%

TIPRANKS
·
Aug 20

JPMorgan Weighs In on Moderna Stock Amid 140%-Plus Jump (And It Ain’t Pretty)

TIPRANKS
·
Aug 20

Eli Lilly on Track for Record High Close

Dow Jones
·
Aug 20

US Equity Indexes Rise as Treasury Yields Ease on Buyback Ramp

MT Newswires Live
·
Aug 20

Twist Bioscience on Track for Highest Close Since 2021 on Work with Anthropic

Dow Jones
·
Aug 20

Eli Lilly Advances Oral Pipeline With New LY4065967 Formulation Study

TIPRANKS
·
Aug 20

Moderna $30 Bln Gain Implies Many Cancer Successes

Reuters
·
Aug 20

Moderna Stock (MRNA) Soars 133%; Five-Star William Blair Analyst Says Strong Cancer Data Could Be a Game-Changer

TIPRANKS
·
Aug 20

S&P 500 Top and Bottom Performing Stocks at About 12:00 P.m. EDT

Reuters
·
Aug 20

Flash Heard: Why Healthcare is Partying Like It's Late 2020

Dow Jones
·
Aug 20

Eli Lilly Stock (LLY) Hits All-Time High as Post-Earnings Rally Continues

TIPRANKS
·
Aug 19

Goldman Sachs Adjusts Price Target on Moderna to $120 From $67, Keeps Neutral Rating

MT Newswires Live
·
Aug 19

Why 2026 is Biotech's Comeback Year

Dow Jones
·
Aug 19

Moderna data bode well for Sellas into imminent readout, says Maxim

TIPRANKS
·
Aug 19

Moderna Moves Back Toward Covid-Era Valuation with Latest mRNA Update

Dow Jones
·
Aug 19

Moderna : RBC Raises Target Price to $130 from $45

THOMSON REUTERS
·
Aug 19

Leerink says cancer vaccine win should sustain Merck momentum into fall

TIPRANKS
·
Aug 19